N. B. Rotllán

SEOM clinical guidelines for the treatment of head and neck cancer (2017)

B. Cirauqui, Y. Escobar, L. I. Docampo, 2017, Clinical & Translational Oncology.

KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).

R. Greil, K. Harrington, A. Psyrri, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

SEOM clinical guidelines for the treatment of head and neck cancer (2017)

B. Cirauqui, Y. Escobar, N. Basté Rotllán, 2017, Clinical and Translational Oncology.